48
Participants
Start Date
March 1, 2020
Primary Completion Date
November 30, 2023
Study Completion Date
November 30, 2023
Hyperbaric oxygen therapy (HBOT) treatment
60 daily hyperbaric oxygen treatment sessions will be administrated 5 days per week. Each session will include exposure of 90 minutes to 100% at 2 ATA, with 5 minutes air breaks every 20 minutes
Cymbalta / Lyrica - Drug treatment
one of the two medications currently licensed for the treatment of FMS in Israel, i.e. Cymbalta and Lyrica. Two medications currently licensed for the treatment of FM in Israel, i.e. Cymbalta and Lyrica. Treatment with Lyrica will start at a dose of 75 mg twice a day, at morning and at bedtime, while treatment with Cymbalta will start at a dose of 30 mg a day (in the morning).
hyperbaric center Asaf harofe medical center, Rishon LeZiyyon
The Emili Sagol Creative Arts Therapies Research Center
UNKNOWN
Assaf-Harofeh Medical Center
OTHER_GOV